Pine Valley Investments Ltd Liability Co Sells 251 Shares of Humana Inc. (NYSE:HUM)

Pine Valley Investments Ltd Liability Co lessened its holdings in Humana Inc. (NYSE:HUM) by 14.5% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,477 shares of the insurance provider’s stock after selling 251 shares during the quarter. Pine Valley Investments Ltd Liability Co’s holdings in Humana were worth $376,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently bought and sold shares of the business. State Street Corp grew its holdings in shares of Humana by 1.0% in the third quarter. State Street Corp now owns 5,357,420 shares of the insurance provider’s stock worth $1,701,582,000 after purchasing an additional 53,272 shares during the last quarter. FMR LLC boosted its position in Humana by 23.4% in the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock valued at $1,073,387,000 after buying an additional 643,291 shares during the period. Pzena Investment Management LLC grew its stake in Humana by 8.1% in the 3rd quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock worth $793,830,000 after acquiring an additional 187,903 shares in the last quarter. Ontario Teachers Pension Plan Board increased its position in shares of Humana by 6.5% during the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock worth $371,705,000 after acquiring an additional 71,910 shares during the period. Finally, Sanders Capital LLC increased its position in shares of Humana by 1.0% during the third quarter. Sanders Capital LLC now owns 1,168,341 shares of the insurance provider’s stock worth $370,060,000 after acquiring an additional 11,923 shares during the period. Institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on HUM. StockNews.com upgraded Humana from a “hold” rating to a “buy” rating in a report on Tuesday. Barclays upped their target price on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and raised their price target for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. TD Cowen upped their price objective on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Finally, Piper Sandler raised their target price on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research report on Wednesday, January 15th. Nineteen analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, Humana currently has a consensus rating of “Hold” and a consensus price target of $285.68.

Insider Buying and Selling

In other news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.32% of the stock is currently owned by company insiders.

Humana Price Performance

Shares of HUM stock opened at $255.06 on Thursday. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The firm has a market capitalization of $30.77 billion, a price-to-earnings ratio of 25.63, a PEG ratio of 2.05 and a beta of 0.56. The stock’s 50-day simple moving average is $270.12 and its 200-day simple moving average is $288.06.

Humana (NYSE:HUM) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, equities analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a yield of 1.39%. Humana’s dividend payout ratio (DPR) is 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.